Healthcare -
Biotechnology - NASDAQ - US
$ 8.885
-1.39 %
$ 1.42 B
Market Cap
-4.08
P/E
Price Target
Average
149.86%
Revenue Forecast
Estimate
2.26%
EBIT
Estimate
4.14%
Net Income
Estimate
30.13%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Novavax, Inc.
Wall Street analysts predict an average 1-year price target for NVAX of $22.2 , with forecasts ranging from
a
low of
$14 to a high of $31 .
NVAX Lowest Price Target
Wall Street Target
14 USD
57.57%
NVAX Average Price Target
Wall Street Target
22.2 USD
149.86%
NVAX Highest Price Target
Wall Street Target
31 USD
248.90%
REVENUE FORECAST
Revenue Forecast Chart NVAX
EBIT FORECAST
EBIT Forecast Chart NVAX
NET INCOME FORECAST
Net Income Chart NVAX